Task: Answer the multiple choice question.
Query: Which compound exhibits a -1.279\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a Cc1nnc(C)c2c(C)n(C(C)c3ccccc3)c(C)c12
b CCOCC(=O)Nc1ccccc1C(=O)N1CCOCC1
Answer: a. Cc1nnc(C)c2c(C)n(C(C)c3ccccc3)c(C)c12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nnc(C)c2c(C)n(C(C)c3ccccc3)c(C)c12
Cc1nnc(C)c2c(C)n(C(C)c3ccccc3)c(C)c12
1,4,5,7-tetramethyl-6-(1-phenylethyl)pyrrolo[3,4-d]pyridazine